Editorial: Is Tranexamic Acid Going to CRASH the Management of Traumatic Brain Injury?
10 Dec, 2019 | 08:34h | UTCOriginal Study: Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial – The Lancet (free study and commentaries)